Clinical trial · Observational
Microwave Ablation of Uterine Fibroids
Prospective Observational Study of Microwave Ablation of Uterine Fibroids (MyoMwa)
NCT07780019CI-TRIAL-00123302MyoMwaactive not recruitingClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This prospective observational study aims to evaluate the effectiveness and acceptability of percutaneous or vaginal ultrasound guided microwave ablation for the treatment or symptomatic uterine fibroids. We will include 100 women.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Uterine Fibroids (Leiomyoma) | Uterine Corpus Leiomyoma | ALIAS | 0.85 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| microwave ablation | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- patients with symptomatic uterine fibroids
- description
- Patients with symptomatic uterine fibroids, who will undergo microwave ablation of fibroids as a clinical treatment are recruited in this study.
- interventionNames
- Procedure: microwave ablation
Primary outcomes (2)
- measure
- Symptom severity of uterine fibroids and quality of life
- timeFrame
- 12 months
- description
- Score of validated form Uterine Fibroid symptom - Quality of life questinnaire. minimum 0, maximum 100 where higher scores indicate higher symptom severity
- measure
- suitability of mwa for general fibroid population
- timeFrame
- 12 months
- description
- objective and subjective outcome of mwa in different fibroid types, sizes and locations
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
- Maximum age
- 56 Years
Show eligibility criteria text
Inclusion Criteria: * symptomatic fibroids * premenopausal status * acceptable risks for general anestesia or sedation * willing to undergo mwa treatment and participate in the study Exclusion Criteria: * postmenopausal status * bleeding disorder with increased risk of bleeding
References
Publications (0)
Data not yet available
No reference posted for this study.